A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer

Tianjin Chest Hospital

Status: Completed

Conditions: Non-small Cell Lung Cancer

Treatments: Procedure: Surgery

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT03429192

TJ-N2LC-01

Details and patient eligibility

About

A study to compare patient survivals in the N2 patients with non-small cell lung cancer in the subgroups of lymph skip metastases and non-skip metastases

Full description

A multi-centre real-world non-interventional observational study to retrospectively collect the study data on patient demographic/tumor biological characteristics and clinical treatments to compare patient survivals in the N2 patients with non-small cell lung cancer in the subgroups of lymph skip metastases and non-skip metastases.

Enrollment: 2,653 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with surgeries from 2014 to 2017;
• Pathologically diagnosed patients with non-small cell lung cancer;
• Age > 18 years old;
• Patients with chest surgeries before hospitalization;
• Patients with N2 lymph nodes (+) after surgeries who received lymphadenectomy (Group 10 and 11 lymph nodes);

Exclusion criteria

• Patients with radiotherapies, chemotherapies and biological therapies for tumors

Trial design

2,653 participants in 1 patient group

N2 non-small cell lung cancer

Description:

Chinese patients with N2 non-small cell lung cancer

Treatment:

Procedure: Surgery